Elevation of interleukin 1 receptor antagonist in the stratum corneum of sun-exposed and ultraviolet B-irradiated human skin

Journal of Investigative Dermatology

Volumn 106, Issue 5, 1996, Pages 1102-1107

  Hirao, Tetsuji ^a   Aoki, Hiroe ^a   Yoshida, Tomoko ^a   Sato, Yoshihisa ^a   Kamoda, Hironobu ^a  

^a Inst for Adv Skin Research Inc   (Japan)

Author keywords

Aging; Keratinocyte differentiation; Regional difference; Turnover

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STRATUM CORNEUM; SUNBURN; ULTRAVIOLET B RADIATION;

EID: 0029882117     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12340143     Document Type: Article

References (54)

1. Ansel JC, Luger TA, Green I: The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes. J Invest Dermatol 81:519-523, 1983
2. Ansel JC, Luger TA, Lowry D, Perry P, Roop DR, Mountz JD: The expression and modulation of IL-1α in murine keratinocytes. J Immunol 140:2274-2278, 1988
3. Arend WP, Smith MF Jr, Janson RW, Joslin FG: IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J Immunol 147:1530-1536, 1991
4. Bigler CF, Norris DA, Weston WL, Arend WF: Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 98:38-44, 1992
5. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
6. Butcher C, Steinkasserer A, Tejura S, Lennard AC: Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. J Immunol 153:701-711, 1994
7. Corradi A, Franzi AT, Rubartelli A: Synthesis and secretion of interleukin-1α and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes. Exp Cell Res 217:355-362, 1995
8. Didierjean L, Salomon D, Merot Y, Siegenthaler G, Shaw A, Dayer JM, Saurat JH: Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermis. J Invest Dermatol 92:809-816, 1989
9. Dinarello CA, Thompson RC: Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 12:404-410, 1991
10. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP: Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transducrion. J Biol Chem 266:10331-10336, 1991
11. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346, 1990
12. Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Brandhuber BJ, Thompson RC: Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 88:5232-5236, 1991
13. Gahring L, Baltz M, Pepys MB, Daynes R: Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin-1 in vivo and in vitro. Proc Natl Acad Sci USA 81:1198-1202, 1984
14. Gahring LC, Buckley A, Daynes RA: Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J Clin Invest 76:1585-1591, 1985
15. Garmyn M, Yaar M, Boileau N, Backendorf C, Gilchrest BA: Effect of aging and habitual sun exposure on the genetic response of cultured human keratinocytes to solar-simulated irradiation. J Invest Dermatol 99:743-748, 1992
16. Gery I, Gershon RK, Waksman BH: Potentiation of the T lymphocyte response to mitogens. I. The responding cell. J Exp Med 136:128-138, 1972
17. Gilchrest BA, Garmyn M, Yaar M: Aging and photoaging affect gene expression in cultured human keratinocytes. Arch Dermatol 130:82-86, 1994
18. Granowitz EV, Clark BD, Mancilla J, Dinarello CA: Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 266:14147-14150, 1991
19. Gruaz D, Didierjean L, Grassi J, Frobert Y, Dayer JM, Saurat JH: Interleukin 1 alpha and beta in psoriatic skin: Enzyme immunoassay, immunoblot studies and effect of systemic retinoids. Dermatologica 179:202-206, 1989
20. Gruaz-Chatellard D, Baumberger C, Saurat JH, Dayer JM: Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes. FEBS Lett 294:137-140, 1991
21. Hammerberg C, Arend WP, Fisher GJ, Chan LS, Berger AE, Haskill JS, Voorhees JJ, Cooper KD: Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest 90:571-583, 1992
22. Haskill S, Martin G, Van Le L, Morris J, Peace A, Bigler CF, Jaffe GJ, Hammerberg C, Sporn SA, Fong S, Arend WP, Ralph P: cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 88:3681-3685, 1991
23. Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM: Interleukin 1 is present in normal human epidermis. J Immunol 136:3317-3323, 1986
24. Horii I, Nakayama Y, Obata M, Tagami H: Stratum corneum hydration and amino acid content in xerotic skin. Br J Dermatol 121:587-592, 1989
25. Janson RW, Hance KR, Arend WP: Production of IL-1 receptor antagonist by human in vitro-derived macrophages. J Immunol 147:4218-4223, 1991
26. Kirnbauer R, Köck A, Neuner P, Förster E, Krutmann J, Urbanski A, Schauer E, Ansel JC, Schwartz T, Luger TA: Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol 96:484-489, 1991
27. Köck A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA: Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172: 1609-1614, 1990
28. Kristensen M, Deleuran B, Eedy DJ, Feldmann M, Breathnach SM, Brennan FM: Distribution of interleukin-1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1α in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis. Br J Dermatol 127:305-311, 1992
29. Kupper TS: Interleukin 1 and other human keratinocyte cytokines: molecular and functional characterization. Adv Dermatol 3:293-308, 1988
30. Kupper TS: The activated keratinocyte: A model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 94:146s-150s, 1990
31. Kutsch CL, Norris DA, Arend WP: Tumor necrosis factor-α induces interleukin-1α and interleukin-1 receptor antagonist production by cultured human keratincytes. J Invest Dermatol 101:79-85, 1993
32. Lennard A, Gorman P, Charrier M, Griffiths S, Scotney H, Sheer D, Solari R: Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene. Cytokine 4:83-89, 1992
33. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
34. Murphy GM, Dowd PM, Hudspith BN, Brostoff J, Greaves MW: Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo. Photodermatology 6:268-274, 1989
35. Nozaki S, Abraham JS, Pearce MK, Sander DN: Augmentation of granulocyte/macrophage colony-stimulating factor expression by ultraviolet irradiation is mediated by interleukin 1 in Pam 212 keratinocytes. J Invest Dermatol 97:10-14, 1991
36. Orino E, Sone S, Nu A, Ogura T: IL-4 up-regulates IL-1 receptor antagonist gene expression and its production in human blood monocytes. J Immunol 149:925-931, 1992
37. Oxholm A, Oxholm P, Staberg B, Bendtzen K: Immunohistological detection of interleukin 1-like molecules and tumor necrosis factor in human epidermis before and after UVB-irradiation in vivo. Br J Dermatol 118:369-376, 1988
38. Plewig G: Regional differences of cell sizes in the human stratum corneum. Part II. Effects of sex and age. J Invest Dermatol 54:19-23, 1970
39. Plewig G, Marples RR: Regional differences of cell sizes in the human stratum corneum. Part I. J Invest Dermatol 54:13-18, 1970
40. Rasmussen HH, Celis JE: Evidence for an altered protein kinase C (PKC) signaling pathway in psoriasis. J Invest Dermatol 101:560-566, 1993
41. Rivas JM, Ullrich SE: Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 149:3865-3871, 1992
42. Roberts D, Marks R: The determination of regional and age variations in the rate of desquamation: a comparison of four techniques. J Invest Dermatol 74:13-16, 1980
43. Romero LI, Ikejima T, Pincus SH: In situ localization of interleukin-1 in normal and psoriatic skin. J Invest Dermatol 93:518-522, 1989
44. Sauder DN, Stanulis-Praegar BM, Gilchrest BA: Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activa ing factor: implications for skin aging. Arch Dermatol Res 280:71-76, 1988
45. Smith MF Jr, Eidlen D, Arend WP, Gutierrez-Hartmann A: LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J Immunol 153:3584-3593, 1994
46. Smith MF Jr, Eidlen D, Brewer MT, Eisenberg SP, Arend WP, Gutierrez-Hartmann A: Human IL-1 receptor antagonist promoter: cell type-specific activity and identification of regulatory regions. J Immunol 149:2000-2007, 1992
47. Takematsu H, Ohmoto Y, Tagami H: Decreased levels of IL-1α and β in psoriatic lesional skin. Tohoku J Exp Med 161:159-169, 1990
48. Takematsu H, Suzuki R, Tagami H, Kumagai K: Interleukin-1-like activity in horny layer extracts: Decreased activity in scale extracts of psoriasis and sterile pustular dermatoses. Dermatologica 172:236-240, 1986
49. Tsai JC, Feingold KR, Crumrine D, Wood LC, Grunfeld C, Elias PM: Permeability barrier disruption alters the localization and expression of TNFα/protein in the epidermis. Arch Dermatol Res 286:242-248, 1994
50. Turner M, Chantry D, Katsikis P, Berger A, Brennan FM, Feldmann M: Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β. Eur J Immunol 21:1635-1639, 1991
51. Urbanski A, Schwartz T, Neuner P, Krutmann J, Kimbauer R, Köck A, Luger TA: Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol 94:808-811, 1990
52. Watt FM, Green H: Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol 90:738-742, 1981
53. Wood LC, Feingold KR, Sequeira-Martin SM, Elias PM, Grunfeld C: Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels. Exp Dermatol 3:56-60, 1994
54. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-487, 1992